Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - CNS Pharmaceuticals, Inc. | StockGist | StockGist

Companies
CNSP
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings CNSPSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

CNS Pharmaceuticals, Inc.

Filed Nov 14, 2025

Accepted Nov 13, 2025, 7:00 PM ET

CIK 0001729427

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

CNS Pharmaceuticals, Inc.

Person Type

IA

CUSIP: 09057N409

Amendment History

3 filings

SCHEDULE 13G
Original
Nov 4, 20250000935836-25-000648
SCHEDULE 13G/A
Amendment 1
Viewing
Nov 14, 20250001172661-25-005174
SCHEDULE 13G/A
Amendment 2
Latest
Feb 13, 20260000935836-26-000092

Recent Filings

CNS Pharmaceuticals, Inc.3 days ago

CNS Pharmaceuticals, Inc.3 weeks ago

CNS Pharmaceuticals, Inc.1 months ago

CNS Pharmaceuticals, Inc.1 months ago

CNS Pharmaceuticals, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice